Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 147

1.

Progress in measurement instruments for acute and chronic gout studies.

Grainger R, Taylor WJ, Dalbeth N, Perez-Ruiz F, Singh JA, Waltrip RW, Schlesinger N, Evans R, Edwards NL, Sivera F, Diaz-Torne C, MacDonald PA, McQueen FM, Schumacher HR.

J Rheumatol. 2009 Oct;36(10):2346-55. doi: 10.3899/jrheum.090371.

PMID:
19820224
2.

Outcome domains for studies of acute and chronic gout.

Schumacher HR, Taylor W, Edwards L, Grainger R, Schlesinger N, Dalbeth N, Sivera F, Singh J, Evans R, Waltrip RW, Diaz-Torne C, MacDonald P, McQueen F, Perez-Ruiz F.

J Rheumatol. 2009 Oct;36(10):2342-5. doi: 10.3899/jrheum.090370.

PMID:
19820223
3.

Outcome evaluations in gout.

Schumacher HR, Taylor W, Joseph-Ridge N, Perez-Ruiz F, Chen LX, Schlesinger N, Khanna D, Furst DE, Becker MA, Dalbeth N, Edwards NL.

J Rheumatol. 2007 Jun;34(6):1381-5.

PMID:
17552064
4.

A modified Delphi exercise to determine the extent of consensus with OMERACT outcome domains for studies of acute and chronic gout.

Taylor WJ, Schumacher HR Jr, Baraf HS, Chapman P, Stamp L, Doherty M, McQueen F, Dalbeth N, Schlesinger N, Furst DE, Vazquez-Mellado J, Becker MA, Kavanaugh A, Louthrenoo W, Bardin T, Khanna D, Simon LS, Yamanaka H, Choi HK, Zeng X, Strand V, Grainger R, Clegg D, Singh JA, Diaz-Torne C, Boers M, Gow P, Barskova VG.

Ann Rheum Dis. 2008 Jun;67(6):888-91. Epub 2007 Nov 29. Erratum in: Ann Rheum Dis. 2008 Nov;67(11):1652.. Mellado, J Vazquez [corrected to Vazquez-Mellado, J].

PMID:
18055475
5.

Establishing outcome domains for evaluating treatment of acute and chronic gout.

Grainger R, Taylor WJ.

Curr Opin Rheumatol. 2008 Mar;20(2):173-8. doi: 10.1097/BOR.0b013e3282f36cf1. Review.

PMID:
18349747
6.

Patient-reported outcomes in chronic gout: a report from OMERACT 10.

Singh JA, Taylor WJ, Simon LS, Khanna PP, Stamp LK, McQueen FM, Neogi T, Gaffo AL, Becker MA, MacDonald PA, Dabbous O, Strand V, Dalbeth ND, Aletaha D, Edwards NL, Schumacher HR Jr.

J Rheumatol. 2011 Jul;38(7):1452-7. doi: 10.3899/jrheum.110271.

7.

Outcome measures in acute gout: a systematic literature review.

Dalbeth N, Zhong CS, Grainger R, Khanna D, Khanna PP, Singh JA, McQueen FM, Taylor WJ.

J Rheumatol. 2014 Mar;41(3):558-68. doi: 10.3899/jrheum.131244. Epub 2013 Dec 15. Review.

8.

OMERACT endorsement of measures of outcome for studies of acute gout.

Singh JA, Taylor WJ, Dalbeth N, Simon LS, Sundy J, Grainger R, Alten R, March L, Strand V, Wells G, Khanna D, McQueen F, Schlesinger N, Boonen A, Boers M, Saag KG, Schumacher HR, Edwards NL.

J Rheumatol. 2014 Mar;41(3):569-73. doi: 10.3899/jrheum.131246. Epub 2013 Dec 15.

9.

Quality of life and disability in patients with treatment-failure gout.

Becker MA, Schumacher HR, Benjamin KL, Gorevic P, Greenwald M, Fessel J, Edwards L, Kawata AK, Frank L, Waltrip R, Maroli A, Huang B; Gout Natural History Study Group, Sundy JS.

J Rheumatol. 2009 May;36(5):1041-8. doi: 10.3899/jrheum.071229. Epub 2009 Mar 30.

PMID:
19332629
10.

Toward a valid definition of gout flare: results of consensus exercises using Delphi methodology and cognitive mapping.

Taylor WJ, Shewchuk R, Saag KG, Schumacher HR Jr, Singh JA, Grainger R, Edwards NL, Bardin T, Waltrip RW, Simon LS, Burgos-Vargas R.

Arthritis Rheum. 2009 Apr 15;61(4):535-43. doi: 10.1002/art.24166.

11.

Outcome measures for acute and chronic gout.

Schumacher HR Jr, Edwards LN, Perez-Ruiz F, Becker M, Chen LX, Furst DE, Joseph-Ridge N, Schlesinger N, Horowitz Z, Saag K, Boice JA, Yamanaka H; OMERACT 7 Special Interest Group.

J Rheumatol. 2005 Dec;32(12):2452-5. Review.

PMID:
16331785
12.

Imaging as an Outcome Measure in Gout Studies: Report from the OMERACT Gout Working Group.

Grainger R, Dalbeth N, Keen H, Durcan L, Lawrence Edwards N, Perez-Ruiz F, Diaz-Torne C, Singh JA, Khanna D, Simon LS, Taylor WJ.

J Rheumatol. 2015 Dec;42(12):2460-4. doi: 10.3899/jrheum.141164. Epub 2015 Feb 1. Review.

13.

Concerns of patients with gout are incompletely captured by OMERACT-endorsed domains of measurement for chronic gout studies.

Diaz-Torne C, Pou MA, Castellvi I, Corominas H, Taylor WJ.

J Clin Rheumatol. 2014 Apr;20(3):138-40. doi: 10.1097/RHU.0000000000000090.

PMID:
24662554
14.

Application of the OMERACT filter to measures of core outcome domains in recent clinical studies of acute gout.

Taylor WJ, Redden D, Dalbeth N, Schumacher HR, Edwards NL, Simon LS, John MR, Essex MN, Watson DJ, Evans R, Rome K, Singh JA.

J Rheumatol. 2014 Mar;41(3):574-80. doi: 10.3899/jrheum.131245. Epub 2014 Jan 15.

15.

Serum urate in chronic gout--will it be the first validated soluble biomarker in rheumatology?

Stamp LK, Khanna PP, Dalbeth N, Boers M, Maksymowych WP, Schumacher HR Jr, Becker MA, MacDonald PA, Edwards NL, Singh JA, Simon LS, McQueen FM, Neogi T, Gaffo AL, Strand V, Taylor WJ.

J Rheumatol. 2011 Jul;38(7):1462-6. doi: 10.3899/jrheum.110273.

16.

Tophus measurement as an outcome measure for clinical trials of chronic gout: progress and research priorities.

Dalbeth N, McQueen FM, Singh JA, MacDonald PA, Edwards NL, Schumacher HR Jr, Simon LS, Stamp LK, Neogi T, Gaffo AL, Khanna PP, Becker MA, Taylor WJ.

J Rheumatol. 2011 Jul;38(7):1458-61. doi: 10.3899/jrheum.110272.

17.

Quality of life and quality of care for patients with gout.

Singh JA.

Curr Rheumatol Rep. 2009 Apr;11(2):154-60. Review.

18.

Fibromyalgia syndrome.

Mease P, Arnold LM, Bennett R, Boonen A, Buskila D, Carville S, Chappell A, Choy E, Clauw D, Dadabhoy D, Gendreau M, Goldenberg D, Littlejohn G, Martin S, Perera P, Russell IJ, Simon L, Spaeth M, Williams D, Crofford L.

J Rheumatol. 2007 Jun;34(6):1415-25.

PMID:
17552068
19.

Serum urate as a soluble biomarker in chronic gout-evidence that serum urate fulfills the OMERACT validation criteria for soluble biomarkers.

Stamp LK, Zhu X, Dalbeth N, Jordan S, Edwards NL, Taylor W.

Semin Arthritis Rheum. 2011 Jun;40(6):483-500. doi: 10.1016/j.semarthrit.2010.09.003. Epub 2010 Nov 5. Review.

PMID:
21056459
20.

Developing a standardized definition for disease "flare" in rheumatoid arthritis (OMERACT 9 Special Interest Group).

Bingham CO 3rd, Pohl C, Woodworth TG, Hewlett SE, May JE, Rahman MU, Witter JP, Furst DE, Strand CV, Boers M, Alten RE.

J Rheumatol. 2009 Oct;36(10):2335-41. doi: 10.3899/jrheum.090369. Epub 2009 Aug 14.

PMID:
19684147
Items per page

Supplemental Content

Write to the Help Desk